Stephen R Saklad

Private

Funding Agency Title Retrospective Review of Carnitine Therapy in Developmentally Disabled Individuals on Valproic Acid Status Complete Period - Present Role Co-Principal Investigator Grant Detail Funding Agency Title Psychogenic Polydipsia and Treatment of Cevimeline Status Active Period - Present Role Principal Investigator Grant Detail Investigator Initiated Protocol in Development Funding Agency Title A Phase 3, Randomized, Active Comparator-controller Clinical Trial to Assess the Long-Term Safety and Efficacy of SM-13496/Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Status Active Period - Present Role Principal Investigator Grant Detail

Funding Agency Title A Randomized, Double-blind, Placebo-controlled and Olanzapine-referenced, Parallel-group Safety and Efficacy Study of Two Fixed Doses of Bifeprunox in the Treatment of Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mgeq., 100 mg eq., and 150 mg ep.) of Paliperidone Palmitate in Subjects With Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Randomized, Crossover Study to Evaluate the Overall Safety and Tolerability of Paliperidone Palmatate Injected in the Deltoid or Gluteus Muscle in Subjects With Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group, Fixed Dose Study of the Effect of Bifeprunox Versus Olanzapine in the Treatment of Outpatients with Schizophrenia - Extension Phase Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group, Fixed Dose Study of the Effect of Bifeprunox versus Olanzapine in the Treatment of Outpatients with Schizophrenia - Extension Phase Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group Fixed-dose Study of the Effect of Weight of Bifeprunox Versus Olanzapine in the Treatment of Outpatients with Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group, Fixed Dose Study of the Effect of Bifeprunox Versus Olanzapine in the Treatment of Outpatients with Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail